4 research outputs found

    Pediculosis capitis: Treatment options among schoolchildren in Greece

    No full text
    Background: Pediculosis capitis remains a significant health problem worldwide. Purpose: It was to record the preferred treatment options against pediculosis capitis in school-age children in Greece. Method and Material: A randomly selected, stratified sample of schools from all over Greece was used. A questionnaire with closed and open-type questions was used. Five thousand, eighty four questionnaires were distributed and 2792 returned. Descriptive statistics was conducted. Results: Median age of the children was 8 (3-13) years. 88,6% of the parents answered the would not visit a dermatologist in the case of pediculosis. Insecticides were the treatment of choice in most cases (80 %), while louse comb as a single treatment was preferred by 1 % of the parents. Conclusion: Drugs remain the main treatment choice in Greece. Dermatologists infrequently treat patients with pediculosis capitis

    Immunoglobulin G4-related Disease: Presentation of the First Case with Isolated Pterygopalatine Fossa Involvement

    No full text
    Immunoglobulin G4-related disease is an immune-mediated fibroinflammatory disease with single or multiple organ involvement. Clinically it mimics several benign and malignant tumors, as well as infectious, and inflammatory disorders. It typically presents as multiple tumor-forming lesions. Histological and immunohistochemical findings are characteristic. Serum immunoglobulin G4 levels are usually increased. Systemic corticosteroid administration is the treatment of choice with good response, especially in early disease stages. We present the first case of immunoglobulin G4-related disease presenting as an isolated tumor forming lesion of the left pterygopalatine fossa. Imaging studies indicated a benign process. Histological findings were consistent with IgG4-related disease. The patient showed a good response to systemic corticosteroid treatment and remains free of symptoms 18 months following diagnosis
    corecore